Ibuprofen/paracetamol

Ibuprofen/paracetamol
Combination of
IbuprofenNonsteroidal anti-inflammatory drug
ParacetamolAnalgesic/antipyretic
Clinical data
Trade namesCombogesic, Advil Dual Action with Acetaminophen, Ibupane
Other namesAcetaminophen/ibuprofen
AHFS/Drugs.comMicromedex Detailed Consumer Information
License data
Pregnancy
category
Routes of
administration		By mouth
ATC code
Legal status
Legal status
Identifiers
CAS Number
KEGG

Ibuprofen/paracetamol, sold under the brand name Combogesic among others, is a fixed-dose combination of two medications, ibuprofen, a non-steroidal anti-inflammatory drug (NSAID); and paracetamol (acetaminophen), an analgesic and antipyretic.[6] It is available as a generic medication.[9][10][11]

  1. ^ a b Cite error: The named reference Ibupane PI was invoked but never defined (see the help page).
  2. ^ "Nuromol Dual Action Pain Relief 200mg/500mg tablets - Summary of Product Characteristics (SmPC)". (emc). 15 June 2022. Archived from the original on 25 February 2023. Retrieved 24 February 2023.
  3. ^ "Nuromol Pain Relief 200mg/500mg Film Coated Tablets - Summary of Product Characteristics (SmPC)". (emc). 15 June 2022. Archived from the original on 25 February 2023. Retrieved 24 February 2023.
  4. ^ "Nuromol public assessment report". GOV.UK. 16 August 2021. Archived from the original on 25 February 2023. Retrieved 24 February 2023.
  5. ^ "Nuromol Dual Action Pain Relief 200mg/500mg tablets (ibuprofen/paracetamol): public consultation". GOV.UK. 13 May 2021. Archived from the original on 25 February 2023. Retrieved 24 February 2023.
  6. ^ a b "Advil Dual Action with Acetaminophen- ibuprofen, acetaminophen tablet, film coated". DailyMed. 1 December 2021. Archived from the original on 25 February 2023. Retrieved 25 February 2023.
  7. ^ "Combogesic- acetaminophen and ibuprofen tablet, film coated". DailyMed. 9 March 2023. Archived from the original on 7 July 2024. Retrieved 6 July 2024.
  8. ^ "Combogesic IV- acetaminophen and ibuprofen injection injection". DailyMed. 29 April 2024. Archived from the original on 7 July 2024. Retrieved 6 July 2024.
  9. ^ "Competitive Generic Therapy Approvals". U.S. Food and Drug Administration (FDA). 29 June 2023. Archived from the original on 29 June 2023. Retrieved 29 June 2023.
  10. ^ "First Generic Drug Approvals 2023". U.S. Food and Drug Administration (FDA). 30 May 2023. Archived from the original on 30 June 2023. Retrieved 30 June 2023.
  11. ^ Cite error: The named reference Drug2015 was invoked but never defined (see the help page).
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.